Tags

Type your tag names separated by a space and hit enter

The effects of soy protein in women and men with elevated plasma lipids.
Biofactors 2000; 12(1-4):251-7B

Abstract

Fifty four postmenopausal women with elevated cholesterol were recruited for a randomised, double-blind controlled trial of soy protein containing isoflavones. (ISP+) or a soy protein with a low isoflavone content (ISP-), taken daily for 12 weeks. There was an overall reduction after 12 weeks in total cholesterol (TC), LDL cholesterol (LDL-C), sex hormone binding globulin (SHBG), and luteinizing hormone (LH). There were no significant differences between treatment groups. In a separate study 27 male subjects with a TC > 5.5 mmol/l were given ISP+ for 12 weeks. In this male study there was a significant increase in HDL cholesterol (HDL-C) and SHBG. Soy protein has a cholesterol lowering effect in both women and men. These studies suggest that this effect is independent of isoflavones. Soy protein also reduces SHBG levels in both sexes.

Authors+Show Affiliations

Sydney Menopause Centre, Royal Hospital for Women, Randwick, NSW, Australia.No affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

11216493

Citation

Mackey, R, et al. "The Effects of Soy Protein in Women and Men With Elevated Plasma Lipids." BioFactors (Oxford, England), vol. 12, no. 1-4, 2000, pp. 251-7.
Mackey R, Ekangaki A, Eden JA. The effects of soy protein in women and men with elevated plasma lipids. Biofactors. 2000;12(1-4):251-7.
Mackey, R., Ekangaki, A., & Eden, J. A. (2000). The effects of soy protein in women and men with elevated plasma lipids. BioFactors (Oxford, England), 12(1-4), pp. 251-7.
Mackey R, Ekangaki A, Eden JA. The Effects of Soy Protein in Women and Men With Elevated Plasma Lipids. Biofactors. 2000;12(1-4):251-7. PubMed PMID: 11216493.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The effects of soy protein in women and men with elevated plasma lipids. AU - Mackey,R, AU - Ekangaki,A, AU - Eden,J A, PY - 2001/2/24/pubmed PY - 2001/4/21/medline PY - 2001/2/24/entrez SP - 251 EP - 7 JF - BioFactors (Oxford, England) JO - Biofactors VL - 12 IS - 1-4 N2 - Fifty four postmenopausal women with elevated cholesterol were recruited for a randomised, double-blind controlled trial of soy protein containing isoflavones. (ISP+) or a soy protein with a low isoflavone content (ISP-), taken daily for 12 weeks. There was an overall reduction after 12 weeks in total cholesterol (TC), LDL cholesterol (LDL-C), sex hormone binding globulin (SHBG), and luteinizing hormone (LH). There were no significant differences between treatment groups. In a separate study 27 male subjects with a TC > 5.5 mmol/l were given ISP+ for 12 weeks. In this male study there was a significant increase in HDL cholesterol (HDL-C) and SHBG. Soy protein has a cholesterol lowering effect in both women and men. These studies suggest that this effect is independent of isoflavones. Soy protein also reduces SHBG levels in both sexes. SN - 0951-6433 UR - https://www.unboundmedicine.com/medline/citation/11216493/The_effects_of_soy_protein_in_women_and_men_with_elevated_plasma_lipids_ L2 - https://content.iospress.com/openurl?genre=article&issn=0951-6433&volume=12&issue=1-4&spage=251 DB - PRIME DP - Unbound Medicine ER -